From: Management of epistaxis in patients with ventricular assist device: a retrospective review
Sex: | VAD Type: |
Male: 37 (75%) | HMII: 39 (79%) |
Female: 12 (25%) | HeartWare: 7 (14%) |
Total: 49 | CentriMag: 2 (4%) |
VentrAssist: 1 (2%) | |
Reason For Admission: | Cause: |
Cardiac: 39 (79%) | Spontaneous: 37 (75%) |
Epistaxis: 6 (12%) | Traumatic: 12 (25%) |
Other: 4 (8%) | |
Location: | Recurrence: |
Anterior Septum: 41 (84%) | < 7 Days: 6 (12%) |
Inferior Turbinate: 9 (18%) | 7–30 Days: 6 (12%) |
Other: 2 (4%) | 1–6 Months: 4 (8%) |
> 6 Months: 28 (57%) | |
Death < 6 Months: 18 (37%) |